Ligand profile
CHEMBL405371
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_2391 — MTA/SAH nucleosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL405371- UniProt (similar protein)
P0AF14- pchembl
- 9.350 (~0.4 nM)
- Target protein
- VK055_2391
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 70.8
- −1 ≤ LogP ≤ 5 1.33
- MW ≤ 500 Da 263.4
- LogP ≤ 5 1.33
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 70.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CSCC1CN(Cc2c[nH]c3c(N)ncnc23)C1CSCC1CN(Cc2c[nH]c3c(N)ncnc23)C1
InChI=1S/C12H17N5S/c1-18-6-8-3-17(4-8)5-9-2-14-11-10(9)15-7-16-12(11)13/h2,7-8,14H,3-6H2,1H3,(H2,13,15,16)InChI=1S/C12H17N5S/c1-18-6-8-3-17(4-8)5-9-2-14-11-10(9)15-7-16-12(11)13/h2,7-8,14H,3-6H2,1H3,(H2,13,15,16)
YTSGCQRBVYKQCC-UHFFFAOYSA-NYTSGCQRBVYKQCC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF01048
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL405371 →
- UniProt UniProt P0AF14 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL405371”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2391.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 33
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).